Wells Fargo’s iShares Biotechnology ETF IBB Stock Holding History

Wells Fargo’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-100	Closed	-$12.7K	–	7226
2025 Q2	$12.7K	Buy	+100	New	+$12.3K	﹤0.01%	5891
2024 Q4	–	Sell	-30,000	Closed	-$4.37M	–	7125
2024 Q3	$4.37M	Hold	30,000	–	–	﹤0.01%	2446
2024 Q2	$4.12M	Hold	30,000	–	–	﹤0.01%	2408
2024 Q1	$4.12M	Buy	+30,000	New	+$4.1M	﹤0.01%	2412
2023 Q2	–	Sell	-200	Closed	-$25.8K	–	7631
2023 Q1	$25.8K	Buy	+200	New	+$26.2K	﹤0.01%	5531
2022 Q4	–	Sell	-12,100	Closed	-$1.42M	–	7575
2022 Q3	$1.42M	Buy	+12,100	New	+$1.5M	﹤0.01%	2994
2020 Q2	–	Sell	-100	Closed	-$1K	–	6516
2020 Q1	$1K	Sell	100 -103,200	-100%	-$11.9M	﹤0.01%	6060
2019 Q4	$4K	Hold	103,300	–	–	﹤0.01%	6074
2019 Q3	$659K	Buy	103,300 +100	+0.1%	+$10.5K	﹤0.01%	4175
2019 Q2	$444K	Buy	+103,200	New	+$11M	﹤0.01%	4455
2018 Q2	–	Sell	-19,600	Closed	-$82K	–	6427
2018 Q1	$82K	Buy	+19,600	New	+$2.17M	﹤0.01%	5389
2014 Q2	–	Sell	-158,400	Closed	-$504K	–	6186
2014 Q1	$504K	Buy	+158,400	New	+$13.2M	﹤0.01%	3870

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo's IBB Position: Q1 2026 in Review

Wells Fargo increased its iShares Biotechnology ETF (IBB) stake by 13% in Q1 2026, buying an estimated $16.7M and bringing the position to 854,345 shares worth $144M. The position accounts for 0.03% of the portfolio, ranked #505.

Wells Fargo first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $163M in Q4 2015. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Wells Fargo held 854,345 shares of iShares Biotechnology ETF worth $144M as of Q1 2026.
Wells Fargo bought 97,919 iShares Biotechnology ETF shares in Q1 2026, an estimated $16.7M.
iShares Biotechnology ETF made up 0.03% of Wells Fargo's portfolio in Q1 2026, its #505 holding.
Wells Fargo first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
Wells Fargo's iShares Biotechnology ETF position peaked at $163M in Q4 2015.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.